# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2071-2080 of 2224 results.
Tumor Registry of Lymphatic Neoplasia
Status: Completed
Last Changed: May 18, 2020
First Received: Apr 29, 2009
Disease(s): Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM)
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies
Status: Recruiting
Last Changed: Oct 01, 2020
First Received: Apr 30, 2019
Disease(s): Phase I: Relapsed or Refractory B-cell Malignancies, Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma, Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic Leukemia
Intervention(s): Acalabrutinib
Locations: Research Site, Beijing, China
Research Site, Beijing, China
Research Site, Beijing, China
Research Site, Changchun, China
Research Site, Changsha, China
... and 19 other locations.
Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia
Status: Completed
Last Changed: Mar 03, 2017
First Received: May 22, 2014
Disease(s): Chronic Lymphocytic Leukemia
Intervention(s): Valproate
Locations: Lund University Hospital, Department of Oncology, Lund, Sweden
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation
Status: Completed
Last Changed: Jul 31, 2019
First Received: Oct 04, 2006
Disease(s): Lymphoma, Leukemia, Transplantation, Stem Cell, Lymphoid Malignancies, Disorder Related to Transplantation
Intervention(s): GM-CSF, Rituximab, NK Cell Infusion
Locations: University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma
Status: Terminated
Last Changed: Apr 23, 2019
First Received: Mar 18, 2015
Disease(s): Lymphoma
Intervention(s): Pegfilgrastim, Loratadine, Placebo, Questionnaires
Locations: University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma
Status: Withdrawn
Last Changed: Apr 21, 2017
First Received: Nov 11, 2016
Disease(s): Lymphoma
Intervention(s): Palifermin, Panobinostat, Gemcitabine, Busulfan, Melphalan, Rituximab, Dexamethasone, Caphosol, Glutamine, Oral Cryotherapy (ice chips), Pyridoxine, Stem Cell Infusion, G-CSF
Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies
Status: Withdrawn
Last Changed: Jun 26, 2018
First Received: Mar 24, 2016
Disease(s): Hematologic Malignancy
Intervention(s): Fludarabine, Cytarabine, Erwinase
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
Status: Completed
Last Changed: Dec 02, 2017
First Received: Jan 28, 2008
Disease(s): Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes
Intervention(s): umbilical cord blood transplantation, Allopurinol, fludarabine phosphate, Cyclophosphamide, Total body irradiation, Treg infusion, Sirolimus
Locations: Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE)
Status: Completed
Last Changed: Nov 06, 2018
First Received: Jul 10, 2014
Disease(s): Tumors With Aberrations in ALK or ROS1
Intervention(s): Ceritinib
Locations: St Joseph Heritage Healthcare St. Joseph Heritage, Santa Rosa, California, United States
Sarah Cannon Research Institute @ HealthONE Presbyterian, Denver, Colorado, United States
Rocky Mountain Cancer Centers Dept of Rocky Mountain (2), Greenwood Village, Colorado, United States
Florida Cancer Specialists Florida Cancer Specialists (31, Fort Myers, Florida, United States
Florida Cancer Specialists Research Institute, Fort Myers, Florida, United States
... and 22 other locations.
Safety and Efficiency Study of ET019003-T Cells in Relapsed, Refractory CD19+ B Cell Leukemia and Lymphoma
Status: Recruiting
Last Changed: Aug 07, 2019
First Received: Jul 10, 2019
Disease(s): CD19+ Leukemia and Lymphoma
Intervention(s): ET019003-T Cells
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China